New pediatric HIV med available

June 15, 2020

The unique formulation is a dispersible tablet for children.

Major Metformin recalls underway

June 08, 2020

Five pharma markers are recalling the diabetes medication due to the presence of a carcinogenic ingredient.

Remdesivir for COVID-19 in short supply

June 08, 2020

HHS says supply could run out by the end of this month.

New antibiotic for hospital-acquired pneumonia available

June 05, 2020

The agency welcomes another option for serious bacterial infections.

Drug’s indication expanded to reduce heart attack, stroke risk

June 02, 2020

Brilinta is already approved to prevent atherothrombotic events in ASC.

Two metformin products recalled, more on the way

June 02, 2020

Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.

FDA approves med for severe malaria

May 28, 2020

IV artesunate is the only drug available in the U.S. to treat the disease.

Top 3 COVID-19 stories this week

May 19, 2020

FDA authorizes first stand-alone, at-home test, plus other top COVID-19 news stories.

FDA clears new antigen, saliva tests for COVID-19

May 11, 2020

Antigen tests, a new category, have a major advantage and disadvantage over COVID-19 tests already approved.